Ultra Clean Gets Distribution Rights for Protein Testing System for Surgical Instrumentation

Comments
Print

Ultra Clean Systems announces that it has secured North American distribution rights for the patented ProReveal Fluorescence Protein Testing System. Created by UK-founded Synoptics Health, this exclusivity creates a business advantage as the ProReveal System represents a significant advance in surgical instrument reprocessing and the resulting patient safety.

By utilizing a highly-sensitive non-toxic spray and fluorescence imaging, the system provides a detection test which checks for the presence of residual protein on surgical instruments after going through a washer disinfector process.  In contrast to methods currently used in U.S. hospitals and surgical centers, ProReveal's test delivers highly accurate and measurable results in real-time 3D which remove any doubt as to whether a "decontaminated" instrument is safe for reuse.

In addition to increased levels of accuracy and consistency, ProReveal provides an ease-of-use that facilitates seamless integration into current reprocessing protocols. Once an instrument is sprayed with a reagent, it is placed into the ProReveal unit, and, using a simple interface, a full-color 2D image is taken of the instrument clearly showing where and how much protein is present.  A 3D representation can also be displayed which shows the concentration of protein.

The devices, sprays and testing procedures were originally developed by David Perrett, professor of bioanalytical science, Nanda K. Nayuni, post-doctoral researcher in bioanalysis, William Harvey Research Institute, Barts & the London School of Medicine and Dentistry, Queen Mary University of London, with the express intention of overcoming the sterilization issues with current procedures.

As for the impact on the market and potential company growth for UCS,  Tom Overbey, director of marketing, says, "It is always our goal to have a competitive edge and having the exclusive rights to the ProReveal System is an invaluable asset towards that objective. On the basis of enhancing patient safety, I am confident that supplying this to the market furthers our mission."

Source: Ultra Clean Systems, Inc.

Comments
comments powered by Disqus